Skip to navigation menu Skip to main content Skip to footer
Severity MArkers for COVID-19 – SMAC

Severity MArkers for COVID-19 – SMAC

Lead Author: Kevin Kain

Year Completed: 31 December 2020

The SMAC study was a prospective observational cohort study that aims to identify predictors of severe clinical outcomes of COVID-19 and mortality in a panel of markers of host immune and endothelial activation.